Comprehensive management of obstructive sleep apnea by telemedicine: Clinical improvement and cost-effectiveness of a Virtual Sleep Unit. A randomized controlled trial
Autoři:
Vera M. Lugo aff001; Onintza Garmendia aff001; Monique Suarez-Girón aff001; Marta Torres aff001; Francisco J. Vázquez-Polo aff005; Miguel A. Negrín aff005; Anabel Moraleda aff001; Mariana Roman aff001; Marta Puig aff001; Concepcion Ruiz aff001; Carlos Egea aff002; Juan F. Masa aff002; Ramon Farré aff002; Josep M. Montserrat aff001
Působiště autorů:
Sleep Unit, Respiratory Department, Hospital Clínic, Barcelona, Spain
aff001; Centro de Investigación Biomédica en Red (CIBER) Enfermedades Respiratorias, Madrid, Spain
aff002; Biophysics and Bioengineering Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
aff003; Institut d’Investigacions Biomèdiques Pi i Sunyer (IDIBAPS), Barcelona, Spain
aff004; Quantitative Methods Department and TiDES Institute, Las Palmas de Gran Canaria University, Las Palmas de Gran Canaria, Spain
aff005; Sleep Unit, Respiratory Department, Alava University Hospital, Vitoria, Spain
aff006; Respiratory Unit, San Pedro de Alcántara Hospital, Cáceres, Spain
aff007; Instituto Universitario de investigación Biosanitaria de Extremadura, Cáceres, Spain
aff008; Medicine Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
aff009
Vyšlo v časopise:
PLoS ONE 14(10)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0224069
Souhrn
Introduction
Obstructive sleep apnea (OSA) is a prevalent disease associated with significant morbidity and high healthcare costs. Information and communication technology could offer cost-effective management options.
Objectives
To evaluate an out-of-hospital Virtual Sleep Unit (VSU) based on telemedicine to manage all patients with suspected OSA, including those with and without continuous positive airway pressure (CPAP) therapy.
Methods
This was an open randomized controlled trial. Patients with suspected OSA were randomized to hospital routine (HR) or VSU groups to compare the clinical improvement and cost-effectiveness in a non-inferiority analysis. Improvement was assessed by changes in the Quebec Sleep Questionnaire (QSQ), EuroQol (EQ-5D and EQ-VAS), and Epworth Sleepiness Scale (ESS). The follow-up was 3 months. Cost-effectiveness was assessed by a Bayesian analysis based on quality-adjusted life-years (QALYs).
Results
The HR group (n: 92; 78% OSA, 57% CPAP) compared with the VSU group (n: 94; 83% OSA, 43% CPAP) showed: CPAP compliance was similar in both groups, the QSQ social interactions domain improved significantly more in the HR group whereas the EQ-VAS improved more in the VSU group. Total and OSA-related costs were lower in the VSU group than the HR. The Bayesian cost-effectiveness analysis showed that VSU was cost-effective for a wide range of willingness to pay for QALYs.
Conclusions
The VSU offered a cost-effective means of improving QALYs than HR. However, the assessment of its clinical improvement was influenced by the choice of the questionnaire; hence, additional measurements of clinical improvement are needed. Our findings indicate that VSU could help with the management of many patients, irrespective of CPAP use.
Klíčová slova:
Diagnostic medicine – Quality of life – Cost-effectiveness analysis – Questionnaires – Sleep – Telemedicine – Polysomnography – Quebec
Zdroje
1. Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015. doi: 10.1038/nrdp.2015.15 27188535
2. Lim DC, Pack AI. Obstructive Sleep Apnea: Update and Future. Annu Rev Med. 2017; 14; 68:99–112. doi: 10.1146/annurev-med-042915-102623 27732789
3. Heatley EM, Harris M, Battersby M, McEvoy RD, Chai-Coetzer CL, Antic NA. Obstructive sleep apnoea in adults: a common chronic condition in need of a comprehensive chronic condition management approach. Sleep Med Rev. 2013. doi: 10.1016/j.smrv.2012.09.004 23434125
4. Walter RJ, Hagedorn SI, Lettieri CJ. Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization. Sleep Med. 2017; 38:73–77. doi: 10.1016/j.sleep.2017.07.020 29031760
5. Montserrat JM, Sánchez-de-la Torre M, Terán J, Egea C. Respiratory Disorders during Sleep: A New Dimension for 2018. Arch Bronconeumol. 2019; 55:122–123. doi: 10.1016/j.arbres.2018.05.012 30054116
6. Isetta V, Ruiz M, Farré R, Montserrat JM. Supporting patients receiving CPAP treatment: the role of training and telemedicine. Obstructive Sleep Apnoea European Respiratory Society; 2015; 280–92. http://dx.doi.org/10.1183/2312508X.10006614.
7. Lugo V, Villanueva JA, Garmendia O, Montserrat JM. The role of telemedicine in obstructive sleep apnea management. Expert Rev Respir Med. 2017; 11:699–709. doi: 10.1080/17476348.2017.1343147 28621155
8. Villanueva JA, Suarez MC, Garmendia O, Lugo V, Ruiz C, Montserrat JM. The role of telemedicine and mobile health in the monitoring of sleep-breathing disorders: improving patient outcomes. Smart Homecare Technology and Telehealth. 2017:4 1–11. https://doi.org/10.2147/SHTT.S108048.
9. Hwang D. Monitoring Progress and Adherence with Positive Air way Pressure Therapy for Obstructive Sleep Apnea: The Roles of Telemedicine and Mobile Health Applications. Sleep Med Clin. 2016; 11:161–71. doi: 10.1016/j.jsmc.2016.01.008 27236054
10. Pépin JL, Tamisier R, Hwang D, Mereddy S, Parthasarathy S. Does remote monitoring change OSA management and CPAP adherence? Respirology. 2017; 22:1508–1517. doi: 10.1111/resp.13183 29024308
11. Isetta V, Negrín MA, Monasterio C, Masa JF, Feu N, Álvarez A, et al. A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial. Thorax. 2015; 70:1054–61. doi: 10.1136/thoraxjnl-2015-207032 26310452
12. Turino C, de Batlle J, Woehrle H, Mayoral A, Castro-Grattoni AL, Gómez S, et al. Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea. Eur Respir J. 2017; 49. doi: 10.1183/13993003.01128-2016
13. Hwang D, Chang JW, Benjafield AV, Crocker ME, Kelly C, Becker KA, et al. Effect of Telemedicine Education and Telemonitoring on Continuous Positive Airway Pressure Adherence. The Tele-OSA Randomized Trial. Am J Respir Crit Care Med. 2018; 197:117–126. doi: 10.1164/rccm.201703-0582OC 28858567
14. Chai-Coetzer CL, Antic NA, Rowland LS, Reed RL, Esterman A, Catcheside PG, et al. Primary care vs specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial. JAMA. 2013; 309:997–1004. doi: 10.1001/jama.2013.1823 23483174
15. Kuna ST. Portable-monitor testing an alternative strategy for managing patients with obstructive sleep apnea. Respir Care. 2010; 55:1196–215. 20800001
16. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997; 20:284–9. doi: 10.1093/sleep/20.4.284 9231954
17. Guerrero A, Embid C, Isetta V, Farre R, Duran-Cantolla J, Parra O, et al. Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring. Sleep. 2014; 37:1363–73. doi: 10.5665/sleep.3932 25083017
18. Parikh R, Touvelle MN, Wang H, Zallek SN. Sleep telemedicine: patient satisfaction and treatment adherence. Telemed J E Health. 2011; 17:609–14. doi: 10.1089/tmj.2011.0025 21859348
19. DeMolles DA, Sparrow D, Gottlieb DJ, Friedman R. A pilot trial of a telecommunications system in sleep apnea management. Med Care. 2004; 42:764–9. doi: 10.1097/01.mlr.0000132353.99209.fe 15258478.
20. Stepnowsky CJ, Palau JJ, Marler MR, Gifford AL. Pilot randomized trial of the effect of wireless telemonitoring on compliance and treatment efficacy in obstructive sleep apnea. J Med Internet Res. 2007; 9:e14. doi: 10.2196/jmir.9.2.e14 17513285
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14:540–5. doi: 10.1093/sleep/14.6.540 1798888
22. Lacasse Y, Bureau MP, Sériès F. A new standardised and self-administered quality of life questionnaire specific to obstructive sleep apnoea. Thorax. 2004; 59:494–9. doi: 10.1136/thx.2003.011205 15170032
23. Badia X, Roset M, Montserrat S, Herdman M, Segura A. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc). 1999; 112 Suppl 1:79–85.
24. Campos-Rodriguez F, Queipo-Corona C, Carmona-Bernal C, Jurado-Gamez B, Cordero-Guevara J, Reyes-Nuñez N, et al. Continuous Positive Airway Pressure Improves Quality of Life in Women with Obstructive Sleep Apnea. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2016; 194:1286–1294. doi: 10.1164/rccm.201602-0265OC 27181196
25. ICH harmonized tripartite guideline—E9 Statistical principles for clinical trials. 5 February 1998.
26. Spanish Wage Structure Survey (2015). Spanish Statistical Office (INE). http://www.ine.es.
27. O’Hagan A, Stevens JW, Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Stat Med. 2001; 15; 20:733–53. doi: 10.1002/sim.861 11241573
28. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004; 13:1203–10. doi: 10.1002/hec.901 15386669
29. Spiegelhalter DJ, Thomas A, Best N, Lunn D. OpenBUGS User Manual, Version 3.0.2, September 2007, 2007.
30. Masa JF, Jiménez A, Durán J, Carmona C, Monasterio C, Mayos M, et al. Visual analogical well-being scale for sleep apnea patients: validity and responsiveness: a test for clinical practice. Sleep Breath. 2011; 15:549–59. doi: 10.1007/s11325-010-0399-3 20686860
31. Abma IL, van der Wees PJ, Veer D, Westert G, Rovers M. Measurement properties of patient-reported outcome measures (PROMs) in adults with obstructive sleep apnea (OSA): A systematic review. Sleep Med Rev. 2016; 28:18–31. 26433776
32. Dullet NW, Geraghty EM, Kaufman T, Kissee JL, King J, Dharmar M, et al. Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants. Value Health. 2017; 2:542–546. doi: 10.1016/j.jval.2017.01.014 28407995
33. Liddy C, McKellips F, Armstrong CD, Afkham A, Fraser-Roberts L, Keely E. Improving access to specialists in remote communities: a cross-sectional study 2017;76:1323493. doi: 10.1080/22423982.2017.1323493 28570207
34. Thaker DA, Monypenny R, Olver I, Sabesan S. Cost savings from a telemedicine model of care in northern Queensland, Australia. Med J Aust. 2013; 199:414–7. doi: 10.5694/mja12.11781 24033216
35. Anttalainen U, Melkko S, Hakko S, Laitinen T, Saaresranta T. Telemonitoring of CPAP therapy may save nursing time. Sleep Breath. 2016; 20:1209–1215. doi: 10.1007/s11325-016-1337-9 27043327
36. Farré R, Navajas D, Montserrat JM. Is Telemedicine a Key Tool for Improving Continuous Positive Airway Pressure Adherence in Patients with Sleep Apnea? Am J Respir Crit Care Med. 2018; 197:12–14. doi: 10.1164/rccm.201709-1791ED 28926279
37. Fields BG, Behari PP, McCloskey S, True G, Richardson D, Thomasson A, et al. Remote Ambulatory Management of Veterans with Obstructive Sleep Apnea. Sleep. 2016; 39:501–9. doi: 10.5665/sleep.5514 26446115
38. Wilson SR, Cram P. Another sobering result for home telehealth—and where we might go next. Arch Intern Med. 2012; 172:779–80. doi: 10.1001/archinternmed.2012.685 22507698
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Experimentally validated simulation of coronary stents considering different dogboning ratios and asymmetric stent positioning
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis